Fred Alger Management, LLC Grifols Sa Transaction History

Fred Alger Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$8.91 - $10.91 $392,040 - $480,040	44,000 Added 11.14%	439,068 $4.01 Million
Q1 2023 May 15, 2023	BUY	$6.65 - $10.69 $272,650 - $438,290	41,000 Added 11.58%	395,068 $2.91 Million
Q1 2022 May 16, 2022	BUY	$10.37 - $12.73 $256,678 - $315,092	24,752 Added 7.52%	354,068 $4.14 Million
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $728,769 - $1.09 Million	71,378 Added 27.67%	329,316 $3.7 Million
Q2 2021 Aug 16, 2021	BUY	$16.62 - $18.94 $604,968 - $689,416	36,400 Added 16.43%	257,938 $4.48 Million
Q3 2020 Nov 13, 2020	BUY	$15.4 - $20.16 $597,520 - $782,208	38,800 Added 21.23%	221,538 $3.84 Million
Q1 2020 May 15, 2020	BUY	$16.28 - $25.63 $252,340 - $397,265	15,500 Added 9.27%	182,738 $3.68 Million
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $58,710 - $70,560	3,000 Added 1.83%	167,238 $3.9 Million
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $911,869 - $1.05 Million	45,938 Added 38.83%	164,238 $3.29 Million
Q2 2019 Aug 14, 2019	BUY	$17.59 - $21.1 $2.08 Million - $2.5 Million	118,300 New	118,300 $2.5 Million
Q1 2019 May 14, 2019	SELL	$18.01 - $20.11 $3.86 Million - $4.31 Million	-214,184 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.44 - $21.53 $488,320 - $602,840	28,000 Added 15.04%	214,184 $3.93 Million
Q3 2018 Nov 14, 2018	SELL	$19.97 - $21.96 $555,425 - $610,773	-27,813 Reduced 13.0%	186,184 $3.98 Million
Q1 2018 May 10, 2018	BUY	$20.31 - $24.95 $4.35 Million - $5.34 Million	213,997 New	213,997 $4.54 Million

167

140M

268K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.83B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.